Advertisement

Opioid Overdose Prevention Toolkit Released by SAMHSA — Physician’s First Watch

Medical News |
October 2, 2013

Opioid Overdose Prevention Toolkit Released by SAMHSA

By Cara Adler

A new toolkit of information on opioid overdose prevention and treatment is available for free from the Substance Abuse and Mental Health Services Administration. With separate sections geared towards prescribers, first responders, and patients, the Opioid Overdose Prevention Toolkit includes evidence-based guidance on safe prescribing practices, use of naloxone, and identification of at-risk patients.

Reader Comments (3)

Parks, Georgia R RN, BA Other Healthcare Professional, Emergency Medicine, SUNY Downstate/ LIC Hospital

What possible required comment could reinforce the clinical necessity for such key information? Health care professionals need all the assistance they can receive for this national crisis in opioid addiction

Julian R.Fuentes MD Physician, Family Medicine/General Practice, Anderson, CA

This is a good idea

ken Jones B.S.,M.S.,M.D. Physician, Family Medicine/General Practice, alliance medical group 2179 ashley phosphate road suite b north charleston sc

great idea

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement